These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 24755947)
1. Identification of a novel nonsense mutation in the rod domain of GFAP that is associated with Alexander disease. Nam TS; Kim JH; Chang CH; Yoon W; Jung YS; Kang SY; Shin BA; Perng MD; Choi SY; Kim MK Eur J Hum Genet; 2015 Jan; 23(1):72-8. PubMed ID: 24755947 [TBL] [Abstract][Full Text] [Related]
2. A novel in-frame GFAP p.E138_L148del mutation in Type II Alexander disease with atypical phenotypes. Kang YR; Lee SH; Lin NH; Lee SJ; Yang AW; Chandrasekaran G; Kang KW; Jin MS; Kim MK; Perng MD; Choi SY; Nam TS Eur J Hum Genet; 2022 Jun; 30(6):687-694. PubMed ID: 35246666 [TBL] [Abstract][Full Text] [Related]
3. Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model. Lee SH; Nam TS; Kim KH; Kim JH; Yoon W; Heo SH; Kim MJ; Shin BA; Perng MD; Choy HE; Jo J; Kim MK; Choi SY BMC Neurol; 2017 Sep; 17(1):175. PubMed ID: 28882119 [TBL] [Abstract][Full Text] [Related]
4. A new mutation in GFAP widens the spectrum of Alexander disease. Brenner M; Messing A Eur J Hum Genet; 2015 Jan; 23(1):1-2. PubMed ID: 24961628 [No Abstract] [Full Text] [Related]
5. Screening for GFAP rearrangements in a cohort of Alexander disease and undetermined leukoencephalopathy patients. Ferreira MC; Dorboz I; Rodriguez D; Boespflug Tanguy O Eur J Med Genet; 2015 Sep; 58(9):466-70. PubMed ID: 26208460 [TBL] [Abstract][Full Text] [Related]
6. Aggregate formation analysis of GFAP Tulyeu J; Tamaura M; Jimbo E; Shimbo H; Takano K; Iai M; Yamashita S; Goto T; Aida N; Tokuhiro E; Yamagata T; Osaka H Brain Dev; 2019 Feb; 41(2):195-200. PubMed ID: 30213442 [TBL] [Abstract][Full Text] [Related]
7. Glial fibrillary acidic protein is pathologically modified in Alexander disease. Lin NH; Jian WS; Snider N; Perng MD J Biol Chem; 2024 Jul; 300(7):107402. PubMed ID: 38782207 [TBL] [Abstract][Full Text] [Related]
8. A case of severe Alexander disease with de novo c. 239 T > C, p.(F80S), in GFAP. Matsumoto A; Tulyeu J; Furukawa R; Watanabe C; Monden Y; Nozaki Y; Mori M; Namekawa M; Jimbo EF; Aihara T; Yamagata T; Osaka H Brain Dev; 2018 Aug; 40(7):587-591. PubMed ID: 29573842 [TBL] [Abstract][Full Text] [Related]
9. Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity. Battaglia RA; Beltran AS; Delic S; Dumitru R; Robinson JA; Kabiraj P; Herring LE; Madden VJ; Ravinder N; Willems E; Newman RA; Quinlan RA; Goldman JE; Perng MD; Inagaki M; Snider NT Elife; 2019 Nov; 8():. PubMed ID: 31682229 [TBL] [Abstract][Full Text] [Related]
10. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease. Tian R; Gregor M; Wiche G; Goldman JE Am J Pathol; 2006 Mar; 168(3):888-97. PubMed ID: 16507904 [TBL] [Abstract][Full Text] [Related]
11. Recessively-Inherited Adult-Onset Alexander Disease Caused by a Homozygous Mutation in the GFAP Gene. Fu MH; Chang YY; Lin NH; Yang AW; Chang CC; Liu JS; Peng CH; Wu KLH; Perng MD; Lan MY Mov Disord; 2020 Sep; 35(9):1662-1667. PubMed ID: 32374915 [TBL] [Abstract][Full Text] [Related]
12. Alexander Disease: A Novel Mutation in GFAP Leading to Epilepsia Partialis Continua. Bonthius DJ; Karacay B J Child Neurol; 2016 Jun; 31(7):869-72. PubMed ID: 26719496 [TBL] [Abstract][Full Text] [Related]
13. Neonatal Alexander Disease: Novel GFAP Mutation and Comparison to Previously Published Cases. Knuutinen O; Kousi M; Suo-Palosaari M; Moilanen JS; Tuominen H; Vainionpää L; Joensuu T; Anttonen AK; Uusimaa J; Lehesjoki AE; Vieira P Neuropediatrics; 2018 Aug; 49(4):256-261. PubMed ID: 29801191 [TBL] [Abstract][Full Text] [Related]
14. Novel deletion mutation in GFAP gene in an infantile form of Alexander disease. Murakami N; Tsuchiya T; Kanazawa N; Tsujino S; Nagai T Pediatr Neurol; 2008 Jan; 38(1):50-2. PubMed ID: 18054694 [TBL] [Abstract][Full Text] [Related]
15. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Prust M; Wang J; Morizono H; Messing A; Brenner M; Gordon E; Hartka T; Sokohl A; Schiffmann R; Gordish-Dressman H; Albin R; Amartino H; Brockman K; Dinopoulos A; Dotti MT; Fain D; Fernandez R; Ferreira J; Fleming J; Gill D; Griebel M; Heilstedt H; Kaplan P; Lewis D; Nakagawa M; Pedersen R; Reddy A; Sawaishi Y; Schneider M; Sherr E; Takiyama Y; Wakabayashi K; Gorospe JR; Vanderver A Neurology; 2011 Sep; 77(13):1287-94. PubMed ID: 21917775 [TBL] [Abstract][Full Text] [Related]
16. Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease. Heaven MR; Wilson L; Barnes S; Brenner M J Biol Chem; 2019 Oct; 294(43):15604-15612. PubMed ID: 31484723 [TBL] [Abstract][Full Text] [Related]
17. Adult Alexander disease with autosomal dominant transmission: a distinct entity caused by mutation in the glial fibrillary acid protein gene. Stumpf E; Masson H; Duquette A; Berthelet F; McNabb J; Lortie A; Lesage J; Montplaisir J; Brais B; Cossette P Arch Neurol; 2003 Sep; 60(9):1307-12. PubMed ID: 12975300 [TBL] [Abstract][Full Text] [Related]
18. A report of two cases of bulbospinal form Alexander disease and preliminary exploration of the disease. Song X; Jiang J; Tian W; Zhan F; Zhu Z; Li B; Tang H; Cao L Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109421 [TBL] [Abstract][Full Text] [Related]
19. Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability. Chen YS; Lim SC; Chen MH; Quinlan RA; Perng MD Exp Cell Res; 2011 Oct; 317(16):2252-66. PubMed ID: 21756903 [TBL] [Abstract][Full Text] [Related]
20. Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis. Yoshida T; Sasaki M; Yoshida M; Namekawa M; Okamoto Y; Tsujino S; Sasayama H; Mizuta I; Nakagawa M; J Neurol; 2011 Nov; 258(11):1998-2008. PubMed ID: 21533827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]